These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 20229688

  • 1. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D.
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
    [Abstract] [Full Text] [Related]

  • 2. Thrombin-activatable fibrinolysis inhibitor.
    Marx PF.
    Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
    [Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
    Bouma BN, Mosnier LO.
    Pathophysiol Haemost Thromb; 2004 Sep; 33(5-6):375-81. PubMed ID: 15692247
    [Abstract] [Full Text] [Related]

  • 4. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
    Foley JH, Kim PY, Mutch NJ, Gils A.
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
    [Abstract] [Full Text] [Related]

  • 5. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J, Hudecek J, Kubisz P.
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [Abstract] [Full Text] [Related]

  • 6. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP, Blombäck M.
    Thromb Res; 2002 Apr 01; 106(1):59-62. PubMed ID: 12165290
    [Abstract] [Full Text] [Related]

  • 7. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L.
    Thromb Haemost; 1997 Jul 01; 78(1):386-91. PubMed ID: 9198184
    [Abstract] [Full Text] [Related]

  • 8. Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction.
    Toh CH.
    Blood Coagul Fibrinolysis; 2003 Jun 01; 14 Suppl 1():S69-71. PubMed ID: 14567541
    [Abstract] [Full Text] [Related]

  • 9. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
    Bajzar L, Jain N, Wang P, Walker JB.
    Crit Care Med; 2004 May 01; 32(5 Suppl):S320-4. PubMed ID: 15118538
    [Abstract] [Full Text] [Related]

  • 10. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
    Grosso G, Vikerfors A, Woodhams B, Adam M, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Svenungsson E, Antovic A.
    Thromb Res; 2017 Oct 01; 158():168-173. PubMed ID: 28669410
    [Abstract] [Full Text] [Related]

  • 11. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE.
    Hamostaseologie; 2007 Sep 01; 27(4):278-81. PubMed ID: 17938767
    [Abstract] [Full Text] [Related]

  • 12. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T.
    Nihon Yakurigaku Zasshi; 2000 Nov 01; 116(5):298-303. PubMed ID: 11215380
    [Abstract] [Full Text] [Related]

  • 13. Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.
    Schadinger SL, Lin JH, Garand M, Boffa MB.
    J Thromb Haemost; 2010 Nov 01; 8(11):2523-9. PubMed ID: 20723026
    [Abstract] [Full Text] [Related]

  • 14. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
    Binette TM, Taylor FB, Peer G, Bajzar L.
    Blood; 2007 Nov 01; 110(9):3168-75. PubMed ID: 17644733
    [Abstract] [Full Text] [Related]

  • 15. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M.
    J Biol Chem; 2002 Jan 11; 277(2):1021-30. PubMed ID: 11684677
    [Abstract] [Full Text] [Related]

  • 16. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN, Meijers JC.
    J Thromb Haemost; 2003 Jul 11; 1(7):1566-74. PubMed ID: 12871292
    [Abstract] [Full Text] [Related]

  • 17. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
    Bouma BN, Meijers JC.
    Semin Hematol; 2004 Jan 11; 41(1 Suppl 1):13-9. PubMed ID: 14872415
    [Abstract] [Full Text] [Related]

  • 18. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
    Antovic JP, Rafik Hamad R, Antovic A, Blombäck M, Bremme K.
    Thromb Haemost; 2002 Oct 11; 88(4):644-7. PubMed ID: 12362237
    [Abstract] [Full Text] [Related]

  • 19. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO.
    J Biol Chem; 2011 Jan 07; 286(1):502-10. PubMed ID: 21041299
    [Abstract] [Full Text] [Related]

  • 20. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ.
    J Thromb Haemost; 2016 Aug 07; 14(8):1629-38. PubMed ID: 27279497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.